Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis
Yalaoui, S.
Archives de l'Institut Pasteur de Tunis 83(1-4): 13-17
2006
ISSN/ISBN: 0020-2509 PMID: 19388592 Document Number: 602877
Rheumatoid arthritis is a multi-factorial autoimmune disease in which patho-physiological mechanisms have been partially elucidated these past few years. These recent advances have led to new and effective treatments that must be started early in the course of the disease. This review focuses on new serological markers, the anti citrullinated peptides antibodies which seem to be useful in early diagnosis and prognosis of rheumatoid arthritis and probably provide new insights in its pathogenesis.
Document emailed within 1 workday
Related Documents
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Hayashi, N.; Kumagai, S. 2010: Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 58(5): 466-479
Barcelos, F.; Abreu, I.; Patto, J.é V.; Trindade, H.él.; Teixeira, A. 2009: Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome Acta Reumatologica Portuguesa 34(4): 608-612
Bobbio-Pallavicini, F.; Caporali, R.; Bugatti, S.; Montecucco, C. 2008: What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies? Journal of Rheumatology 35(10): 1903-1905
Awwad, H.M.; Aboukhamis, I.A. 2010: Diagnostic Performances of Anti-Cyclic Citrullinated Peptide Antibodies type IgM, IgA and IgG in Syrian Patients with Rheumatoid Arthritis Clinical Laboratory 56(3-4): 95-102
Lequerré, T.; Richez, C. 2012: Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis La Revue du Praticien 62(8): 1088-1089
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420
Girelli, F.; Foschi, F.G.; Bedeschi, E.; Calderoni, V.; Stefanini, G.F.; Martinelli, M.G. 2004: Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? European Annals of Allergy and Clinical Immunology 36(4): 127-130
Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y. 2007: Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis Journal of Rheumatology 34(9): 1944-1945
Toes, R.E.; van der Woude, D. 2011: ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis Acta Reumatologica Portuguesa 36(3): 205-207
Ramírez, Súl.; Ramírez, Mía.G.; Muñoz, Jé.F.; Martínez, G.E.; Velarde, E.E.; Sánchez, P.E. 2019: Association of KIR2DL2 gene with anti-cyclic citrullinated protein antibodies for serodiagnosis in rheumatoid arthritis Medicina 79(3): 161-166
Youinou, P.; Le Goff, P.; Miossec, P.; L'Hostis, D.; Pennec, Y.; Schwarzberg, C.; Ferrec, C. 1983: Anti-perinuclear antibodies in the diagnosis and prognosis of rheumatoid polyarthritis Revue du Rhumatisme et des Maladies Osteo-Articulaires 50(6): 441-446
Caro-Oleas, J.L.; Fernández-Suárez, A.; Reneses Cesteros, S.; Porrino, C.; Núñez-Roldán, A.; Wichmann Schlipf, I. 2008: Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up Clinical and Experimental Rheumatology 26(3): 461-463
Bohuon, C.; Bellet, D.; Bidart, J.M.; Motte, P. 1987: Significance of anti-peptide monoclonal antibodies in the assessment of tumor markers Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 142(4-5): 268-275
Jansen, T.L.T.A.; Bruyn, G.A.W. 2004: Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis Journal of rheumatology 31(5): 1012-3; author reply 1013
Rezuş, E.; Grigoriu, A.; Rezuş, C. 2009: Aggressive nature of rheumatic arthritis with citrullinated cyclic peptide antibodies Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 73-78
Youinou, P.; Le Goff, P.; Miossec, P.; Moineau, M.P.; Ferec, C. 1983: Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis Zeitschrift für Rheumatologie 42(1): 36-39
Meyer, O.; Semmache, M.; Cyna, J.; Mitrovic, D.; Ryckewaert, A. 1983: Anti-collagen antibodies. their detection in rheumatoid polyarthritis, chronic atrophic polychondritis and various chronic inflammatory rheumatism Revue du Rhumatisme et des Maladies Osteo-Articulaires 50(7): 493-499